Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 4.17
- Piotroski Score 4.00
- Grade Outperform
- Symbol (ANIK)
- Company Anika Therapeutics, Inc.
- Price $16.32
- Changes Percentage (-4.4%)
- Change -$0.75
- Day Low $16.15
- Day High $17.24
- Year High $29.12
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$5.24
- Trailing P/E Ratio -4.92
- Forward P/E Ratio -4.92
- P/E Growth -4.92
- Net Income $-82,667,000
Income Statement
Quarterly
Annual
Latest News of ANIK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Trump, Stefanik campaign for vulnerable NY Republicans as Big Apple kicks off early voting
Former President Trump is campaigning in New York for House Republicans, emphasizing early voting. Trump and GOP leaders are rallying supporters to boost enthusiasm for upcoming elections, aiming to f...
By Fox News | 1 week ago -
'Cult of corruption': Stefanik tears into Dems after Eric Adams indictment
New York Republicans plan to use Mayor Adams' legal issues against Democrats in key battlegrounds. Stefanik criticized the "cult of corruption" in the NY Democratic Party, calling for Adams to resign....
By POLITICO | 1 month ago -
Stefanik: Harris CNN joint interview with Walz is 'offensive to ALL women'
Rep. Elise Stefanik criticized VP Harris for her joint interview with Gov. Tim Walz, calling it "offensive" to women. Harris faced criticism for lack of media interviews, with Republicans questioning ...
By The Hill | 2 months ago